Wells Fargo Maintains Overweight on Scotts Miracle Gro, Lowers Price Target to $60
Wells Fargo analyst Chris Carey maintains Scotts Miracle Gro (NYSE:SMG) with a Overweight and lowers the price target from $77 to $60.
Stocks · News reference
Scotts Miracle-Gro Reaffirms FY Adjusted EPS Of $4.30-$4.45; Timing And Scale Of Future Share Buybacks Remain Secondary To The Company’s Commitment To Ongoing Debt Reduction And Will Be Subject To Market Conditions And Other Factors Determined By Management
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Stifel Maintains Buy on Scotts Miracle Gro, Lowers Price Target to $75
Stifel analyst W. Andrew Carter maintains Scotts Miracle Gro (NYSE:SMG) with a Buy and lowers the price target from $76 to $75.
8-K/A filing — SCOTTS MIRACLE-GRO CO (SMG)
Filed: 2026-09-25 AccNo: 0000825542-26-000054 Size: 171 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ScottsMiracle-Gro Advances Debt Reduction and Capital Allocation
ScottsMiracle-Gro (SMG) redeemed $250 million in senior notes, renewed a $750 million receivables facility, and initiated a $500 million share repurchase program with $25 million repurchased in August 2026. The company achieved its $275 million free cash flow target and expects to reduce leverage to the high-3x range, reaffirming fiscal 2026 guidance while focusing on operational excellence and its SMG 2.0 growth strategy.